glp 1 and gallbladder issues GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Can you get approved for

[49] In a phase III double-blind, randomized, controlled trial supported by Eli Lilly, nondiabetic adults with a body mass index of 30 or more, or 27 or more and at least one weight-related complication, excluding diabetes, were randomized to receive once-weekly, subcutaneous tirzepatide (5, 10, or 15 mg) or placebo

The Beers Criteria, a guideline for medication use in older adults, lists NSAIDs as potentially inappropriate due to high risk of GI bleeds and renal failure

Given the research-use-only status of most of these compounds, buy only from vendors that publish third-party Certificates of Analysis confirming purity, and talk to a physician before starting any peptide protocol, especially one involving injectable compounds with limited human safety data

That doesn't automatically mean fat gain